News & Insights

The latest on investor advocacy.

Featured

27 articles found

BH

MedPageToday – Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

#Assertio Holdings, Inc. (ASRT)
Nov 22, 2024
Media Coverage +1
BH

Open Letter to U.S. Senate

#Assertio Holdings, Inc. (ASRT)
Nov 15, 2024
Campaign Materials +1
BH

Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio

#Assertio Holdings, Inc. (ASRT)
Nov 15, 2024•7 min read
News +1
BH

E-Mail from Spectrum Employee Asked to Delete Adverse Events from Clinical Data

#Assertio Holdings, Inc. (ASRT)
Nov 11, 2024
Campaign Materials +1
BH

Spectrum Site Audit Report Citing ‘Major’ Clinical Trial Data Inaccuracies, Discrepancies, and Lack of Clinical Staff Training)

#Assertio Holdings, Inc. (ASRT)
Nov 11, 2024
Campaign Materials +1
BH

Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio

#Assertio Holdings, Inc. (ASRT)
Nov 11, 2024•8 min read
News +1
BH

Open Letter to Investors of Assertio Holdings, Inc.

#Assertio Holdings, Inc. (ASRT)
Nov 8, 2024
Campaign Materials +1
BH

Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud

#Assertio Holdings, Inc. (ASRT)
Nov 8, 2024•8 min read
News +1
BH

Harvard Law School – Activism Vulnerability Report

#Assertio Holdings, Inc. (ASRT)
Oct 1, 2024
Media Coverage +1
BH

Private Letter from BHG to Assertio Board of Directors

#Assertio Holdings, Inc. (ASRT)
Sep 27, 2024
Campaign Materials +1
BH

Private Letter from Assertio Counsel to BHG Counsel

#Assertio Holdings, Inc. (ASRT)
Sep 25, 2024
Campaign Materials +1
BH

Private Letter from BHG Counsel to Assertio Counsel

#Assertio Holdings, Inc. (ASRT)
Sep 19, 2024
Campaign Materials +1
Page 1 of 3
Next